| Univariate analysis | Multivariate analysis |
---|
Hazard ratio (95% CI) | p value | Hazard ratio (95% CI) | p value |
---|
Neural invasion | 0.05–0.95 | 0.043 | 0.03–0.73 | 0.019 |
SUVmax | 0.08–0.98 | 0.047 | 0.08–7.06 | 0.81 |
TLG | 0.23–1.13 | 0.095 | 0.15–3.11 | 0.63 |
Shape sphericity | 0.09–0.99 | 0.049 | 0.03–0.94 | 0.042 |
Histogram kurtosis | 0.12–0.92 | 0.034 | 0.08–3.54 | 0.50 |
GLCM contrast | 0.16–0.99 | 0.048 | 0.01–5.93 | 0.35 |
GLCM homogeneity | 0.16–1.10 | 0.078 | 0.07–21.16 | 0.89 |
GLCM dissimilarity | 0.16–0.99 | 0.048 | NA* | NA* |
GLRLM HGRE | 0.15–1.10 | 0.076 | 0.05–79.60 | 0.74 |
GLRLM SRHGE | 0.15–1.10 | 0.076 | NA* | NA* |
GLRLM GLNU | 0.22–1.10 | 0.082 | 0.62–7.51 | 0.23 |
GLZLM HGZE | 0.12–0.97 | 0.043 | 0.02–30.49 | 0.91 |
GLZLM SZHGE | 0.12–0.97 | 0.043 | NA* | NA* |
GLZLM LZLGE | 0.23–1.10 | 0.085 | 0.05–0.63 | 0.0076 |
GLZLM GLNU | 0.20–1.01 | 0.054 | 0.09–2.07 | 0.29 |
- CI confidence interval, SUVmax maximum standardized uptake value, TLG total lesion glycolysis, GLCM grey-level co-occurrence matrix, GLRLM grey-level run length matrix, HGRE high grey-level run emphasis, SRHGE short-run high grey-level emphasis, (GLRLM) GLNU grey-level nonuniformity for run, LZLGE long-zone low grey-level emphasis, GLZLM grey-level zone length matrix, HGZE high grey-level zone emphasis, SZHGE short-zone high grey-level emphasis, LZLGE long-zone low grey-level emphasis, (GLZLM) GLNU grey-level nonuniformity for zone, NA* not available due to multicollinearity between (1) GLCM contrast and GLCM dissimilarity (Pearson correlation coefficient r = 0.95 in pre-harmonization and 0.97 in post-harmonization), (2) GLRLM HGRE and GLRLM SRHGE (r = 0.9996 in pre-harmonization and 0.9993 in post-harmonization), and (3) GLZLM HGZE and GLZLM SZHGE (r = 0.99 in pre-harmonization and 0.99 in post-harmonization)